Statements (56)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:awards |
Best workplace awards
|
| gptkbp:clinicalTrials |
Cardiology
Cell therapy Gastroenterology Gene therapy Immunology Nephrology Oncology Pain management Respiratory diseases Transplantation Neurology Infectious diseases Bone health Endocrinology Hematology Vaccines Dermatology Metabolic disorders Chronic diseases Biologics Rare diseases Conducts_clinical_trials_in_Brazil |
| gptkbp:collaborations |
Academic institutions
|
| gptkbp:communityInvolvement |
Health education programs
|
| gptkbp:employees |
Approximately 500
|
| gptkbp:focus |
Research_and_Development
|
| gptkbp:foundedIn |
2001
|
| gptkbp:headquarters |
gptkb:São_Paulo
|
| https://www.w3.org/2000/01/rdf-schema#label |
Amgen Brazil
|
| gptkbp:industry |
Biotechnology
|
| gptkbp:investmentFocus |
Significant investment in R&D
|
| gptkbp:locatedIn |
gptkb:Brazil
|
| gptkbp:market |
Strong_presence_in_Latin_America
|
| gptkbp:mission |
To serve patients
|
| gptkbp:offers |
Therapeutics for cancer
Therapeutics for cardiovascular disease Therapeutics for kidney disease Therapeutics_for_bone_health |
| gptkbp:partnerships |
NGOs
Local healthcare organizations |
| gptkbp:partOf |
Amgen_Global_Network
|
| gptkbp:products |
Biopharmaceuticals
|
| gptkbp:regulatoryCompliance |
ANVISA
|
| gptkbp:researchFocus |
Innovative medicines
|
| gptkbp:socialResponsibility |
Health initiatives
|
| gptkbp:subsidiary |
gptkb:Amgen_Inc.
|
| gptkbp:sustainabilityInitiatives |
Environmental responsibility programs
|
| gptkbp:values |
Innovation
Integrity Respect Teamwork Excellence |
| gptkbp:vision |
Transforming the lives of patients
|
| gptkbp:website |
www.amgen.com.br
|